SEC Tracker
Get the app

Quantumzyme QGAI

Quantumzyme Q1 FY26: revenue $0; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Quantumzyme reported for Q1 FY26, the quarter ended Oct 31, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$0No year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income−$50KNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS$0.00No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$184No year-earlier figure tagged10-Q balance sheet, on EDGAR
  5. Cash from operations−$20KNo year-earlier figure tagged10-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Quantumzyme files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2860 and related industry codes: the same peer list as the financial tables.

  1. SolarWindow Technologies WNDW public float $6M, Feb 28, 2025, over 18 months old
  2. TOMI Environmental Solutions TOMZ public float $12M, Jun 30, 2025
  3. SUIC Worldwide Holdings SUIC public float $1M, Dec 31, 2025